Page last updated: 2024-08-17

quinoxalines and Basal Ganglia Diseases

quinoxalines has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dixon, AK; Gull, P; Hoyer, D; Jaton, AL; Markstein, R; McAllister, K; Rüdeberg, C; Urwyler, S	1

Other Studies

1 other study(ies) available for quinoxalines and Basal Ganglia Diseases

Article	Year
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:3 Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Basal Ganglia Diseases; Catalepsy; Cattle; Dopamine Antagonists; Humans; In Vitro Techniques; Limbic System; Male; Mice; Motor Activity; Prolactin; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Sympathectomy, Chemical	1996

Article

Year

SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.

Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:3

Topics: Acetylcholine; Adenylyl Cyclases; Animals; Apomorphine; Basal Ganglia Diseases; Catalepsy; Cattle; Dopamine Antagonists; Humans; In Vitro Techniques; Limbic System; Male; Mice; Motor Activity; Prolactin; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Dopamine D1; Retina; Sympathectomy, Chemical

1996